Malave Lauren B, Broderick Patricia A
Department of Physiology, Pharmacology and Neuroscience, The Sophie Davis School, The City College of New York , New York, New York. ; Department of Biology, CUNY Graduate Center , New York, New York. ; Center for Advanced Technology (CAT) CUNY , New York, New York.
Department of Physiology, Pharmacology and Neuroscience, The Sophie Davis School, The City College of New York , New York, New York. ; Department of Biology, CUNY Graduate Center , New York, New York. ; Center for Advanced Technology (CAT) CUNY , New York, New York. ; Department of Neurology, NYU Langone Medical Center , New York, New York.
J Caffeine Res. 2014 Jun 1;4(2):35-40. doi: 10.1089/jcr.2014.0004.
It is well known that the reinforcing properties of cocaine addiction are caused by the sharp increase of dopamine (DA) in the reward areas of the brain. However, other mechanisms have been speculated to contribute to the increase. Adenosine is one system that is associated with the sleep-wake cycle and is most important in regulating neuronal activity. Thus, more and more evidence is pointing to its involvement in regulating DA release. The current study set out to examine the role of adenosine in cocaine-induced DA release. Increasing doses of cocaine, caffeine, and their combination, as well as, 8-cyclopentyltheophylline (CPT), an adenosine A1 antagonist (alone and in combination with cocaine) were used to denote a response curve. A novel biosensor, the BRODERICK PROBE was implanted in the nucleus accumbens to image the drug-induced surge of DA release , in the freely moving animal in real time. Combinations of cocaine and caffeine were observed to block the increased release of DA moderately after administration of the low dose (2.5 mg/kg cocaine and 12.5 mg/kg caffeine) and dramatically after administration of the high dose (10 mg/kg cocaine and 50 mg/kg caffeine), suggesting neuroprotection. Similarly, CPT and cocaine showed a decreased DA surge when administered in combination. Thus, the low and high dose of a nonselective adenosine antagonist, caffeine, and a moderate dose of a selective adenosine antagonist, CPT, protected against the cocaine-induced DA release. These results show a significant interaction between adenosine and DA release and suggest therapeutic options for cocaine addiction and disorders associated with DA dysfunction.
众所周知,可卡因成瘾的强化特性是由大脑奖赏区域中多巴胺(DA)的急剧增加引起的。然而,人们推测其他机制也促成了这种增加。腺苷是一个与睡眠-觉醒周期相关的系统,在调节神经元活动方面最为重要。因此,越来越多的证据表明它参与调节DA的释放。当前的研究旨在探讨腺苷在可卡因诱导的DA释放中的作用。使用递增剂量的可卡因、咖啡因及其组合,以及一种腺苷A1拮抗剂8-环戊基茶碱(CPT)(单独使用以及与可卡因联合使用)来描绘一条反应曲线。一种新型生物传感器——布罗德里克探针被植入伏隔核,以实时成像自由活动动物体内药物诱导的DA释放激增情况。观察到可卡因和咖啡因的组合在低剂量(2.5毫克/千克可卡因和12.5毫克/千克咖啡因)给药后适度阻断了DA释放的增加,在高剂量(10毫克/千克可卡因和50毫克/千克咖啡因)给药后显著阻断,表明具有神经保护作用。同样,CPT和可卡因联合使用时显示DA激增减少。因此,低剂量和高剂量的非选择性腺苷拮抗剂咖啡因以及中等剂量的选择性腺苷拮抗剂CPT都能防止可卡因诱导的DA释放。这些结果显示了腺苷与DA释放之间存在显著相互作用,并为可卡因成瘾及与DA功能障碍相关的疾病提示了治疗选择。